Insilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too

Insilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too



Insilico’s Co-CEO Has Big Hopes That Fibrosis Drug Can Reverse Aging Too
Alex Zhavoronkov, founder and co-chief executive of techbio company Insilico, is among the scientists who have devoted countless hours to studying aging.